Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment

Torsten Falk; Stephen L. Cowen

doi:10.4103/nrr.nrr-d-25-00176

September 29, 2025Neural Regeneration ResearchOpen Access

Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment

View Full Paper

Ask AI

Bookmark

Share

Key Points

Ketamine treatment leads to significant systems changes in the motor cortex, impacting dyskinesia symptoms.
The analysis shows molecular changes that could provide insights into treating levodopa-induced dyskinesia.
This study utilizes detailed assessments of both systems and molecular changes caused by ketamine administration.
These findings highlight the potential of ketamine as a therapy for levodopa-induced dyskinesia, indicating further research is necessary.

Implication

This observational analysis reveals systems and molecular changes after ketamine treatment in dyskinesia patients, suggesting potential therapeutic benefits.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Falk et al. (2025) studied this question.

synapsesocial.com/papers/68dd89defe798ba2fc497cc8 https://doi.org/10.4103/nrr.nrr-d-25-00176

View Full Paper

Ask AI

Bookmark

Share

Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Motor cortex in levodopa-induced dyskinesia: Systems and molecular changes after sub-anesthetic ketamine treatment

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading